A report from RAND finds a substantial geographical variation in the US health care system’s ability to diagnose and treat early Alzheimer’s disease with disease-modifying therapies. It states that engaging primary care providers could reduce wait times for specialists and increase the number of people treated with these therapies. The report recommends new training for primary care providers and improving reimbursement rates as key recommendations. It addresses challenges in screening, diagnosis, pricing, coverage, and delivery of therapies and emphasizes the need to evaluate primary care-led models of care and integrate technological advancements. The full report is available at www.rand.org.
Source link
Alzheimer’s treatment roadblocks can be eased by engaging primary care providers in screenings
